Purde, Mette-Triin
Niederer, Rebekka
Wagner, Nikolaus B.
Diem, Stefan
Berner, Fiamma
Hasan Ali, Omar
Hillmann, Dorothea
Bergamin, Irina
Joerger, Markus
Risch, Martin
Niederhauser, Christoph
Lenz, Tobias L.
Früh, Martin
Risch, Lorenz
Semela, David
Flatz, Lukas http://orcid.org/0000-0001-9683-8390
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_157448)
Lungenliga Schweiz (KLS-4409-02-2018)
Eberhard Karls Universität Tübingen
Article History
Received: 26 July 2021
Accepted: 25 November 2021
First Online: 7 December 2021
Declarations
:
: NBW reported an advisory role for Sanofi and travel support from AbbVie and Amgen. MF reported grants from Bristol–Myers Squibb outside of the submitted work and advisory role for AstraZeneca, Merck Sharp & Dohme, Roche, Bristol–Myers Squibb, and Boehringer Ingelheim. LF reported grants outside of the submitted work from Hookipa Pharma and Novartis Foundation as well as an advisory role for Novartis, Sanofi, and Bristol–Myers Squibb. All other authors reported no competing interests.
: The study was approved by the Ethics Committee of Eastern Switzerland (project number EKOS 2016-00998). The study was conducted in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from all participants prior to study enrolment.
: Written consent for publication of data was obtained from all participants prior to study enrolment.